Cell therapy company Cartherics has announced a new licensing agreement with UniQuest, the University of Queensland’s commercialisation company, and the University of Sydney.
-
Latest News Cartherics announces new licensing agreement for innovative cardiac cell therapy July 25, 2024
-
Latest News LTR Pharma completes $10.5 million placement to expedite commercialisation of nasal spray July 25, 2024LTR Pharma (ASX:LTP) has announced that it has received firm commitments to raise $10.5 million before costs to advance the development of its innovative nasal spray treatment for erectile dysfunction.
-
Latest News Chimeric Therapeutics says first patient enrolled in cell therapy trial July 23, 2024Australian cell therapy company Chimeric Therapeutics has announced that the first patients have been enrolled in the new clinical trial of its CHM CDH17 in patients with different forms of cancer.
-
AusBiotech AusBiotech Early-Stage Innovation Forum opens July 23, 2024AusBiotech is calling for expressions of interest from researchers and inventors interested in pitching their innovations at our upcoming Early Stage Innovation Forum, which will be held at the AusBiotech 2024 national conference in Melbourne.
-
Latest News Noxopharm says several companies evaluating its assets July 23, 2024Noxopharm (ASX:NOX) says a range of companies are evaluating its Sofra platform after signing several Material Transfer Agreements.
-
Latest News Neuren secures Rare Pediatric Disease Designation from FDA July 23, 2024Neuren Pharmaceuticals (ASX:NEU) has received a Rare Paediatric Disease Designation from the US FDA for NNZ-2591 in Phelan-McDermid syndrome.
-
Latest News Australian medtech EMVision unveils backpack-sized brain scanner to empower first responders July 23, 2024EMVision (ASX:EMV) has unveiled its First Responder Proof of Concept device for deployment via road and air ambulances.
-
Latest News The New Medicines Manufacturing Innovation Centre opens at Monash July 11, 2024Victorian Deputy Premier and Minister for Medical Research Ben Carroll has officially opened the newly built Medicines Manufacturing Innovation Centre in the Monash Technology Precinct.
-
AusBiotech Nominations sought for new shared MRFF and NHMRC advisory committees July 11, 2024Shared advisory committees are to be established following the Australian Government’s consultation on improving alignment between the Department of Health and Aged Care’s Medical Research Future Fund and NHMRC’s Medical Research Endowment Account.
-
Latest News Zelira says it advances HOPE autism drug program with US FDA meeting July 11, 2024Zelira Therapeutics (ASX:ZLD) has announced an advancement in its HOPE autism drug program following a meeting with the US FDA.
-
Latest News Orthocell receives regulatory approval to commence sales of Striate+ in Canada July 11, 2024Regenerative medicine company Orthocell (ASX:OCC) has announced that Heath Canada has granted a Medical Device Licence for its product, Striate+, for guided bone regeneration in dental implant procedures.
-
Latest News Telix welcomes CMS proposal to improve payment for specialised diagnostic radiopharmaceuticals July 11, 2024Telix Pharmaceuticals (ASX:TLX) has welcomed proposed changes announced by the US Centers for Medicare and Medicaid Services.
-
AusBiotech announces the appointment of its new board chair July 9, 2024“It’s an extraordinary privilege to be appointed Chair of AusBiotech and to lead our organisation in partnership with the Board and our CEO, Rebekah Cassidy, at such a pivotal time for our members," said Dr James Campbell.
-
Latest News Orthocell reports record quarterly and yearly revenue July 9, 2024Regenerative medicine company Orthocell (ASX:OCC) has reported record revenue for the June quarter and year with growth in sales of its medical devices, Striate+ and Remplir.
-
Latest News Florey biotech spin-out secures seed investment from Curie.Bio July 9, 2024Melbourne-based Alkira Bio, a novel drug discovery platform company, has announced an investment from US venture capital firm Curie.Bio.
-
Latest News Opyl partners with L39 Capital to launch AI biotech fund utilising TrialKey technology July 9, 2024AI-driven clinical trial design and optimisation Opyl (ASX:OPL) has announced a strategic partnership with L39 Capital to establish a Biotech Fund.
-
Latest News Genetic Technologies' GeneType to enter Canadian and New Zealand markets July 9, 2024Genetic Technologies (ASX:GTG) has introduced geneType’s suite of genetic risk assessment tests to Canada and New Zealand.
New Stories
-
LTR Pharma completes $10.5 million placement to expedite commercialisation of nasal spray
July 25, 2024 - - Latest News -
Remembering Nobel Laureate Professor Robin Warren AC
July 25, 2024 - - AusBiotech -
Orthocell moves ahead on global market expansion with seven new regulatory applications
July 25, 2024 - - Latest News -
Telix completes significant raise that could be used for acquisitions
July 25, 2024 - - Latest News -
Cartherics announces new licensing agreement for innovative cardiac cell therapy
July 25, 2024 - - Latest News -
AusBiotech Early-Stage Innovation Forum opens
July 23, 2024 - - AusBiotech -
Neuren secures Rare Pediatric Disease Designation from FDA
July 23, 2024 - - Latest News